Navigation Links
Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Date:11/16/2011

eptable bioavailability profile;
  • Cenderitide's PK profile achieved steady-state when delivered through subcutaneous infusion;
  • Weight-based dosing reduced PK variability, as compared to a fixed dosing regimen.

  • "We believe the data from this trial proves that dosing cenderitide with subcutaneous pump technology is a viable strategy for dosing heart failure patients in the out-patient setting," said Hsiao Lieu, MD, Vice President of Clinical Research at Nile. "We now believe that we understand the target dose range for continuous subcutaneous delivery of cenderitide to heart failure patients.  In the next clinical trial, a Phase 2 trial, we hope to test our hypothesis that cenderitide can help reduce hospital re-admission in the post-acute period following ADHF."

    "When dosed continuously in the out-patient setting during the post-acute period, we believe cenderitide has the potential to reduce the re-hospitalization rate following ADHF," said Richard Brewer, Executive Chairman Nile. "If effective, cenderitide may be able to fundamentally change the treatment paradigm of ADHF, potentially reducing the overall financial burden of heart failure on the system."

    About Heart Failure
    Heart failure is the fastest-growing clinical cardiac disease in the U.S. according to the American Heart Association, affecting over 5 million Americans. Over 1 million patients in the U.S. each year are hospitalized with ADHF, an acute exacerbation of heart failure. ADHF is the is the most frequent cause of hospital admission in the U.S. for patients older than 65 years, generating annual inpatient costs of more than $35 billion. Within 90 days following admission for ADHF, approximately 40% of patients return to the hospital. Nile believes that a decrease in the ADHF re-hospitalization rate, which is the clinical target of the cenderitide development program, could both improve the quality of life for patients and decrease the ann
    '/>"/>

    SOURCE Nile Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    2. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    3. Orexigen® Therapeutics Reports Third Quarter Financial Results
    4. Silence Therapeutics Provides Corporate and Development Update
    5. Halozyme Therapeutics Reports Third Quarter 2011 Financial Results
    6. Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System at the Transcatheter Cardiovascular Therapeutics (TCT) Symposium 2011
    7. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
    8. Halozyme Therapeutics Announces Data From Two Phase 1 Studies of PEGPH20 Demonstrating Targeting of Hyaluronan in Tumor Stroma
    9. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
    10. Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline
    11. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)... DALLAS , Sept. 18, 2014 /PRNewswire-iReach/ -- ... and China Acetic Acid Industry" and "2014 Deep ... Industry" reports to its research database. ... 2014 Deep Research Report on Global and China ... research report on China ...
    (Date:9/18/2014)... Texas (PRWEB) September 18, 2014 ... Chancellor John Sharp, Texas A&M Health Science Center ... U.S. Department of Health and Human Services (HHS), ... dedicated a national pandemic influenza vaccine manufacturing facility ... as an anchor for the Texas A&M Biocorridor ...
    (Date:9/18/2014)... Sept. 18, 2014 Research and Markets ... Human Albumin Industry Report 2014" report to their ... Report 2014 is a professional and in-depth study on ... The report provides a basic overview of ... structure. The human albumin market analysis is provided for ...
    (Date:9/18/2014)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology ... cancer, announced today that Daniel P. Gold , Ph.D., ... NewsMakers in the Biotech Industry conference on Friday, September ... Broadway Hotel & Conference Center in New York ... accessed at www.meipharma.com . A replay will be available ...
    Breaking Biology Technology:Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 2Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 4Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
    ... that are trying to justify RFID investment wholly on ... and shrinkage in their supply chain are merely deluding ... opportunities in these areas, it means that gross inefficiencies ... achieve major improvements even without applying RFID. , ,The ...
    ... group of business and technology leaders is asking Wisconsin ... state funds for the Biomedical Technology Alliance ... and private industry in southeastern Wisconsin. , ,The funding ... margin of 15-1, and endorsed by the Doyle administration, ...
    ... Inc., has appointed Michael Eleftheriou as its president ... of experience in the information technology sector, had a ... as president of its Systems Integration business. He has ... and the Middle East. , ,Since 2002, Eleftheriou has ...
    Cached Biology Technology:The key to finding RFID's ROI 2The key to finding RFID's ROI 3The key to finding RFID's ROI 4Budget axe could cut SE Wisconsin tech alliance funding 2Budget axe could cut SE Wisconsin tech alliance funding 3
    (Date:9/18/2014)... world, are the ideal animal in which to study ... the ocean into tens of thousands of freshwater streams ... skeleton to adapt to the new environment. , Breeding ... have turned up one of the genes that controls ... that gene,s regulation in a freshwater population is associated ...
    (Date:9/18/2014)... up to 400 kilometres in search of a home, which ... Clownfish spend their entire adult lives under the protection of ... open ocean, says study co-author, Dr Hugo Harrison from the ... at James Cook University. , "In the past we haven,t ... rare glimpse into how far they can swim, crossing large ...
    (Date:9/17/2014)... From accessible and affordable health care to reproductive ... depend on the ability of people to identify ... openly and respectfully, and find the most defensible ... practices to support these societal conversations?, The Hastings ... of Bioethical Issues have teamed up to publish ...
    Breaking Biology News(10 mins):Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3Nemo's epic journey to find a new home 2Why bioethics literacy matters 2Why bioethics literacy matters 3
    ... a new imaging system that allows them to see ... work, which could help scientists understand how precancerous mutations ... to pinpoint the number and location of mutant cellscells ... the researchers worked with mouse pancreatic cells. "Understanding ...
    ... When individuals infected with HIV become infected with a ... can exchange genetic information, creating a third, recombinant strain ... presence of multiple viral strains, called superinfection, frequently leads ... Now a study from the Partners AIDS Research ...
    ... from four leading cancer centers have confirmed that an analysis ... which lung cancer patients will have the worst survival. The ... help determine who needs more aggressive treatment. The study, ... Medicine . The researchers looked at 442 lung ...
    Cached Biology News:MIT researchers offer glimpse of rare mutant cells 2Viral recombination another way HIV fools the immune system 2Gene panel predicts lung cancer survival, study finds 2
    Collected from sexually mature, mixed sex, mixed breed cats. Physiochemical constituents are measured to ensure lot-to-lot consistency....
    Complete cell culture media with cytokines...
    ... pump available in single head (T2-04 SH) or ... in portable air and gas applications. Delivering flow ... in environments where DC operation, high performance, low ... Offers ultra-compact size, long life, and high ...
    ... linear motor and ballscrew technologies, ... Cartesian solutions that include all ... and motors., , XY ... through high-flex cabling for power, ...
    Biology Products: